Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

boostAGErx vs Medro

boostAGErx
Graded #201

Higher grade

vs+2.499999999999993
Medro
Graded #252

Lower grade

The verdict

boostAGErx takes it — 66.1/100 to 63.6/100.

boostAGErx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. boostAGErx is a longevity-focused telehealth service selling compounded GLP-1 weight management alongside peptide therapy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +24
74
50
Dose & formulationMedro +13
64
77
Clinical oversightboostAGErx +3
74
71
Labs & monitoringEven
52
52
FulfillmentMedro +7
85
92
Contract termsMedro +8
25
33
boostAGErx · left barMedro · right bar

The numbers

MetricboostAGErxMedro
WeighScore66.1/10063.6/100
GradeCC
Scorecard rank#201#252
Semaglutide$95/mo (billed every 28 days, compounded)$199/mo (compounded)
Tirzepatide$145/mo (billed every 28 days, compounded)$299/mo (compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
boostAGErx

Graded #201 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
  • The terms call the charge a 'membership fee' while the marketing carousel says 'No Membership Fees Ever'
  • Prices are rendered entirely in JavaScript; the page's HTML body is empty, so nothing is readable without running the bundle
  • Shipped compounded medication is non-refundable
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Medro

Graded #252 · C

Strengths

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

Where it loses points

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard